SEC Comment Letter for SCYNEXIS INC (SCYX) (CIK 0001178253) (SCYX) — Sep 11, 2018
SCYNEXIS INC (SCYX) (CIK 0001178253)
Date: Sept. 11, 2018 · CIK: 0001178253 · Accession: 0000000000-18-028195
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227167
Letter
September 10, 2018 Marco Taglietti, M.D. Chief Executive Officer Scynexis, Inc. 1 Evertrust Plaza, 13th Floor Jersey City, NJ 07302-6548 Re:Scynexis, Inc. Registration Statement on Form S-3 Filed August 31, 2018 File No. 333-227167 Dear Dr. Taglietti: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Matthew B. Hemington, Esq.
Show Raw Text
September 10, 2018
Marco Taglietti, M.D.
Chief Executive Officer
Scynexis, Inc.
1 Evertrust Plaza, 13th Floor
Jersey City, NJ 07302-6548
Re:Scynexis, Inc.
Registration Statement on Form S-3
Filed August 31, 2018
File No. 333-227167
Dear Dr. Taglietti:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Matthew B. Hemington, Esq.